PRODUCT DETAIL

Rapibloc 20 mg/2 ml koncentrát na injekčný roztok

Code

1310C

MA number

13/0445/16-S

Product Form:

con inj 5x2 ml (amp.skl.)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

MAH, country:

Amomed Pharma GmbH, Austria

Therapeutic Class:

13 - ANTIARRYTHMICA

ATC:

C	CARDIOVASCULAR SYSTEM
C07	BETA BLOCKING AGENTS
C07A	BETA BLOCKING AGENTS
C07AB	Beta blocking agents, selective
C07AB14	Landiolol

Shelf life:

Container:

glass ampoule

Route of admin.:

Intravenous use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 8(3) application - new active substance
MA issued:	29.09.2016
SPC:	SPC_Rapibloc 20 mg/2 ml koncentrát na injekčný roztok_02_2022.pdf
PIL:	PIL_Rapibloc 20 mg/2 ml ml koncentrát na injekčný roztok_10_2021.pdf
Safety feature	Yes
Data update:	28.10.2021